Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

This Is How the ‘Ozempic Face’ Is Treated: Treatments Beyond Surgery

Summary by La Vanguardia
In recent years, peptide receptor agonists similar to glucagon type 1 (GLP-1), such as semaglutide (commercialized as Ozempic or Wegovy), have revolutionized the treatment of obesity and type 2 diabetes.Clinical trials reviewed by organisms such as Cochrane show significant weight loss (- > 10-16 % in 1-2 years); their therapeutic efficacy has been consolidated.Continue reading...

1 Articles

La VanguardiaLa Vanguardia
Lean Left

This Is How the ‘Ozempic Face’ Is Treated: Treatments Beyond Surgery

In recent years, peptide receptor agonists similar to glucagon type 1 (GLP-1), such as semaglutide (commercialized as Ozempic or Wegovy), have revolutionized the treatment of obesity and type 2 diabetes.Clinical trials reviewed by organisms such as Cochrane show significant weight loss (- > 10-16 % in 1-2 years); their therapeutic efficacy has been consolidated.Continue reading...

·Granada, Spain
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

La Vanguardia broke the news in Granada, Spain on Friday, April 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Obesity icon

Obesity

Ozempic icon

Ozempic

Wegovy icon

Wegovy

Spain icon

Spain

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal